IRLAB Therapeutics
IRLAB | ST
Overview
Corporate Details
- ISIN(s):
- SE0012675361 (+1 more)
- LEI:
- 549300JAT34LHEI0DH60
- Country:
- Sweden
- Address:
- Arvid Wallgrens backe 20, 413 46 Göteborg
- Website:
- https://irlab.se/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
IRLAB Therapeutics is a drug discovery and development company focused on creating novel treatments for neurodegenerative conditions and disorders of the central nervous system (CNS), with a primary emphasis on Parkinson's disease. The company leverages its proprietary and resource-efficient research platform, the Integrative Screening Process (ISP), to generate its drug pipeline. The ISP platform is built on a systems pharmacology discovery approach and utilizes an extensive, unique database of CNS compounds. Key clinical-stage candidates include Mesdopetam (IRL790), in development for treating levodopa-induced dyskinesia (LIDs), and Pirepemat (IRL752), aimed at treating impaired balance and falls associated with Parkinson's disease.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for IRLAB Therapeutics.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-29 07:00 |
Declaration of Voting Results & Voting Rights Announcements
Ändring av antalet aktier och röster i IRLAB Therapeutics AB
|
Swedish | 47.7 KB | |
| 2025-08-29 07:00 |
Declaration of Voting Results & Voting Rights Announcements
Change in number of shares and votes in IRLAB Therapeutics AB
|
English | 47.0 KB | |
| 2025-08-27 07:00 |
Interim Report
|
Swedish | 377.6 KB | |
| 2025-08-27 07:00 |
Interim Report
|
English | 373.0 KB | |
| 2025-08-21 11:00 |
Board/Management Information
IRLAB appoints Roy Jonebrant as interim CFO
|
English | 38.2 KB | |
| 2025-08-21 11:00 |
Board/Management Information
IRLAB utser Roy Jonebrant till tillförordnad CFO
|
Swedish | 38.8 KB | |
| 2025-08-11 09:00 |
Board/Management Information
IRLAB's CFO Viktor Siewertz leaves the company for a new leading position
|
English | 39.6 KB | |
| 2025-08-11 09:00 |
Board/Management Information
IRLAB:s CFO Viktor Siewertz lämnar bolaget för ny ledande position
|
Swedish | 40.0 KB | |
| 2025-07-18 18:31 |
Share Issue/Capital Change
IRLAB announces the outcome of the company’s rights issue
|
English | 64.4 KB | |
| 2025-07-18 18:31 |
Share Issue/Capital Change
IRLAB offentliggör utfall i bolagets företrädesemission
|
Swedish | 64.4 KB | |
| 2025-07-14 07:00 |
Share Issue/Capital Change
Sista dag för handel med teckningsrätter i IRLAB:s företrädesemission
|
Swedish | 55.9 KB | |
| 2025-07-14 07:00 |
Share Issue/Capital Change
Last day of trading in subscription rights in IRLAB’s rights issue
|
English | 56.0 KB | |
| 2025-07-03 07:00 |
Share Issue/Capital Change
The subscription period in IRLABS’s rights issue of shares commence today
|
English | 57.2 KB | |
| 2025-07-03 07:00 |
Share Issue/Capital Change
Idag inleds teckningsperioden i IRLAB:s företrädesemission av aktier
|
Swedish | 57.4 KB | |
| 2025-07-02 15:00 |
Prospectus
IRLAB offentliggör informationsdokument i samband med företrädesemissionen
|
Swedish | 56.0 KB |
Automate Your Workflow. Get a real-time feed of all IRLAB Therapeutics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for IRLAB Therapeutics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-05 | Kristina Torfgård | Other | Buy | 9,000 | 140,850.00 SEK |
| 2024-08-05 | Kristina Torfgård | Other | Buy | 4,500 | 70,875.00 SEK |
| 2024-05-14 | Gunnar Olof Olsson | Other | Buy | 2,000 | 31,000.00 SEK |
| 2024-05-10 | Daniel Johnsson | Other | Buy | 20,000 | 259,680.00 SEK |
| 2023-04-03 | Joakim Tedroff | Other | Buy | 51,430 | 2,038,685.20 SEK |
| 2022-09-01 | Richard Godfrey | Other | Buy | 5,000 | 174,457.00 SEK |
| 2022-08-30 | Viktor Siewertz | Other | Buy | 40 | 1,420.00 SEK |
| 2022-08-29 | Viktor Siewertz | Other | Sell | 40 | 1,408.00 SEK |
| 2022-07-15 | Joakim Tedroff | Other | Other | 84,148 | N/A |
| 2022-05-31 | Viktor Siewertz | Other | Buy | 4,500 | 170,370.00 SEK |
